Suppr超能文献

倍半萜内酯衍生物的制备:细胞毒性活性和作用选择性。

Preparation of Sesquiterpene Lactone Derivatives: Cytotoxic Activity and Selectivity of Action.

机构信息

INTEQUI-CONICET, Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis, Almirante Brown 1445, CP D5700HGC, San Luis, Argentina.

CONICET-Universidad de Buenos Aires. Instituto de Química y Metabolismo del Fármaco (IQUIMEFA), Junín 956 2°P (1113), Buenos Aires, Argentina.

出版信息

Molecules. 2019 Mar 20;24(6):1113. doi: 10.3390/molecules24061113.

Abstract

Cancer is one of the most important causes of death worldwide. Solid tumors represent the great majority of cancers (>90%) and the chemotherapeutic agents used for their treatment are still characterized by variable efficacy and toxicity. Sesquiterpene lactones are a group of naturally occurring compounds that have displayed a diverse range of biological activities including cytotoxic activity. A series of oxygenated and oxy-nitrogenated derivatives (⁻) from the sesquiterpene lactones cumanin (), helenalin (), and hymenin () were synthesized. The silylated derivatives of helenalin, compounds and , were found to be the most active against tumor cell lines, with GI values ranging from 0.15 to 0.59 μM. The ditriazolyl cumanin derivative () proved to be more active and selective than cumanin in the tested breast, cervix, lung, and colon tumor cell lines. This compound was the least toxic against splenocytes (CC = 524.1 µM) and exhibited the greatest selectivity on tumor cell lines. This compound showed a GI of 2.3 µM and a SI of 227.9 on WiDr human colon tumor cell lines. Thus, compound can be considered for further studies and is a candidate for the development of new antitumor agents.

摘要

癌症是全球最重要的死亡原因之一。实体瘤占癌症的绝大多数(>90%),用于治疗这些肿瘤的化疗药物仍然存在疗效和毒性差异。倍半萜内酯是一组天然存在的化合物,具有多种生物活性,包括细胞毒性活性。我们合成了一系列倍半萜内酯(−)中的氧代和氮代衍生物,包括 cumanin()、helenalin()和 hymenin()。发现硅烷化的 helenalin 衍生物化合物和具有最强的抗肿瘤细胞系活性,GI 值范围为 0.15 到 0.59 μM。二氮唑基 cumanin 衍生物()在测试的乳腺癌、宫颈癌、肺癌和结肠癌肿瘤细胞系中比 cumanin 更具活性和选择性。该化合物对脾细胞的毒性(CC = 524.1 μM)最小,对肿瘤细胞系的选择性最高。该化合物对 WiDr 人结肠肿瘤细胞系的 GI 为 2.3 μM,SI 为 227.9。因此,化合物可以考虑进一步研究,是开发新型抗肿瘤药物的候选药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00b5/6471591/a1ee27f5bb87/molecules-24-01113-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验